Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 21 Glioblastoma 5 Endometrial Neoplasms 5 Breast Neoplasms 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Leukoplakia, Oral 3 Insulin Resistance 3 Ovarian Neoplasms 2 Metabolic Syndrome 2 Metabolic Diseases 2 Medulloblastoma 2 Infertility 2 Erythroplasia 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Adenocarcinoma Of Esophagus 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thyroid Diseases 1 TP53 Y220C Mutation 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Rectal Neoplasms 1 Prostate Cancer Recurrent 1 Prediabetic State 1 Posterior Fossa Ependymal Tumor 1 Pleural Effusion, Malignant 1

Interventions

Capecitabine 41 Oxaliplatin 39 Fluorouracil 29 Leucovorin 23 Radiotherapy 21 Cetuximab 14 Bevacizumab 14 Irinotecan 13 Nivolumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Surgical Procedures, Operative 8 Folfox protocol 8 Drug Therapy 8 pembrolizumab 7 Radiotherapy, Intensity-Modulated 7 Chemoradiotherapy 7 Biopsy 7 trifluridine tipiracil drug combination 6 Radiation 6 tislelizumab 5 sintilimab 5 regorafenib 5 dehydroftorafur 5 X-Rays 5 Surveys and Questionnaires 5 Sigmoidoscopy 5 Endoscopy 5 Consolidation Chemotherapy 5 spartalizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Metformin × 1 year × Clear all

NCT02437656 2026-03-31

METCAP

Centre Oscar Lambret

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡